Updates on Optic Disc Drusen

Retina is producing Phase 3 results faster than ever, but FDA approval doesn't necessarily convey how a drug will fit into practice. Dr. Ehsan Rahimy joins host Dr. Jay Sridhar to unpack recent and somewhat puzzling trial results involving tyrosine kinase inhibitors, IL-6 inhibit ...  Show more

Artificial intelligence is rapidly recasting how we interact with our world and our patients. In today's epside, host Dr. Amanda Redfern welcomes Dr. Chris Kelly, Chief Health Information Officer at Oregon Health and Science University (OHSU), to provide an inside look at tools a ...  Show more

Dr. Andy Southerland talks with Dr. Andrea Lendaris about her experience of having Usher syndrome type 2A along with her journey of having acute and chronic health challenges.  This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. Disclosures can be ...  Show more

Dr. Drew Carey speaks with Dr. Tongalp H. Tezel on his study comparing patients with nonarteritic ischemic optic neuropathy (NAION) with healthy non-NAION patients with crowded discs and noncrowded optic discs. From his Ophthalmology article, "

The latest guidelines on disease-modifying treatment in multiple sclerosis (MS) from the Association of British Neurologists is discussed in this intercontinental podcast with perspectives from the UK, the USA, and Australia.   Participants: <ul> <li>Professor Alasdair Coles is H ...  Show more